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Abstract: Defective cellular trafficking of aquaporin-5 (AQP5) to the apical plasma membrane
(APM) in salivary glands is associated with the loss of salivary fluid secretion. To examine
mechanisms of α1-adrenoceptor (AR)-induced trafficking of AQP5, immunoconfocal microscopy
and Western blot analysis were used to analyze AQP5 localization in parotid tissues stimulated
with phenylephrine under different osmolality. Phenylephrine-induced trafficking of AQP5 to the
APM and lateral plasma membrane (LPM) was mediated via the α1A-AR subtype, but not the
α1B- and α1D-AR subtypes. Phenylephrine-induced trafficking of AQP5 was inhibited by ODQ
and KT5823, inhibitors of nitric oxide (NO)-stimulated guanylcyclase (GC) and protein kinase (PK)
G, respectively, indicating the involvement of the NO/ soluble (c) GC/PKG signaling pathway.
Under isotonic conditions, phenylephrine-induced trafficking was inhibited by La3+, implying the
participation of store-operated Ca2+ channel. Under hypotonic conditions, phenylephrine-induced
trafficking of AQP5 to the APM was higher than that under isotonic conditions. Under non-stimulated
conditions, hypotonicity-induced trafficking of AQP5 to the APM was inhibited by ruthenium red
and La3+, suggesting the involvement of extracellular Ca2+ entry. Thus, α1A-AR activation induced
the trafficking of AQP5 to the APM and LPM via the Ca2+/ cyclic guanosine monophosphate
(cGMP)/PKG signaling pathway, which is associated with store-operated Ca2+ entry.
Keywords: aquaporin-5; α1A-adrenoceptor; α1B-adrenoceptor; α1D-adrenoceptor; calcium; protein G
kinase; hypotonicity
1. Introduction
Salivary secretion is regulated by both sympathetic and parasympathetic nerves [1]. Activation
of M1- and M3-muscarinic acetylcholine receptors (mAChRs) and α1-adrenoceptors (ARs) induce an
increase in the cytosolic concentration of calcium ([Ca2+]i) and stimulate salivary fluid secretion [2].
Activation of β-adrenoceptors activates protein kinase (PK) A and also induces secretion of saliva
containing high concentrations of protein [1]. Aquaporins (AQPs) are integral membrane proteins
that facilitate water transport across the cellular membranes [3]. Thirteen AQPs have been identified
in mammals [4]. AQP5 is expressed highly in salivary glands, lacrimal glands, lung, and so on [5].
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Studies with knockout mice lacking AQP5 show defective fluid secretion, indicating a pivotal role for
AQP5 in salivary fluid secretion [6].
Saliva is secreted from three major (parotid, submandibular and sublingual) glands and numerous
minor glands. The submandibular, sublingual and minor salivary glands continuously secrete saliva,
whereas the parotid glands do not contribute to unstimulated salivary secretion, but contribute
to stimulated secretion [1,7]. In in vitro studies using rat parotid gland slices, the interactions of
acetylcholine (ACh) and epinephrine with M3-mAChRs [8] and α1-ARs [9], respectively, induce a rapid
trafficking of AQP5 to the apical plasma membrane (APM) via the enhanced [Ca2+]i. In vivo studies
using confocal microscopy demonstrated that activation of M3- and M1-mAChRs induces the rapid
trafficking of AQP5 associated with lipid rafts from the cytoplasm to the APM [10–12]. The activation
of M3- and M1-mAChRs also induces the release of AQP5 and lipid rafts into the saliva [13]. AQP5 is
identified in parotid gland exosomes [14], which are packed in cytosolic multivesicular bodies.
Upon fusion of multivesicular bodies with the APM in a Ca2+-triggered manner, AQP5 is released into
the saliva.
The α1-ARs subfamily consists of three (α1A, α1B and α1D) subtypes [15]. In rat parotid glands,
the presence of mRNA and receptor protein for both the α1A- and α1B-AR subtypes, along with
detectable α1D-AR mRNA, has been confirmed [16,17]. α1-AR antagonists are widely used in the
treatment of lower urinary tract symptoms (LUTS) [18–22] and cardiovascular diseases [23]. However,
α1-AR antagonists cause dry mouth as a side effect [24]. The α1A-AR is linked to G-protein Gq/11
signaling and a subsequent rise in [Ca2+]i, while the α1B-AR activates the mitogen-activated kinase
(MAPK)/extracellular signal-regulated kinase 1 and 2 (ERK1/2) [25,26].
In the present work, we investigated the mechanisms underlying the translocation of AQP5 in
association with the α1-AR, as well as the associated signal transduction. Furthermore, we investigated
the responsiveness of AQP5 trafficking to an α1-AR agonist under different osmolality, in light of
the recent reports that hyper- and hypo-tonicity induce trafficking of AQP5 in several tissues [27–31].
The hypotonic conditions activate the transient receptor potential (TRPV) 4 and induce the trafficking of
AQP5 to the APM in human salivary gland cells [28] and reduction of AQP5 in lung epithelial cells [29].
In the cochlea, the hypertonicity induces the trafficking of AQP5 to the APM [30]. On the other hand, it
is reported that TRPV4 seems to play a role during cholinergic activation in immortalized salivary cell
line [32]. To clarify the relationship between α1-AR activation, osmolality and TRPV4, the mechanisms
underlying α1-AR induced the trafficking of AQP5 were investigated under different osmolality in rat
parotid glands.
2. Results
2.1. α1-AR Agonist-Induced Trafficking of AQP5 and Ganglioside GM1 to the APM and Lateral Plasma
Membrane (LPM)
Our previous studies demonstrated that AQP5 is translocated to the APM in response to activation
of M3-mAChR [8] or α1-ARs [9] in vitro. Recently, published results from in vivo experiments revealed
that the activation of M3- and M1-mAChRs induces the translocation of AQP5, together with lipid
rafts, from the cytoplasm to the APM [11,12]. In the present study, we used confocal microscopy to
directly visualize the cellular distribution and translocation of AQP5 in rat parotid glands under α1-AR
activation. Phenylephrine (nonspecific α1-AR agonist) (0.25 mg/kg) was injected into the tail vein of
rats. After 0 min (control), AQP5 (Figure 1a; A) and GM1 (Figure 1b; A) labeling was present in the
APM, scattered in LPM, and large amounts of AQP5 and GM1 were diffusely distributed throughout
the cytoplasm and in the apical plasmalemmal region. GM1 was used as a marker of lipid rafts [33].
After 3 min, AQP5 (Figure 1a; B) and GM1 (Figure 1b; B) showed similar staining patterns to those of
control (Figure 1a,b; A). However, after 6 to 10 min, AQP5 (Figure 1a; C and D) and GM1 (Figure 1b;
C and D) were located predominantly in the APM and LPM.
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Figure 1. Immunohistochemical analysis of aquaporin-5 (AQP5) and ganglioside GM1 distributions 
in rat parotid acinar cells after phenylephrine injection. Parotid glands were obtained from rats 0 (A), 
3 (B), 6 (C), and 10 (D) min after phenylephrine (0.25 mg/kg) injection. Tissue sections were fixed in 
ethanol followed by incubation with anti-AQP5 (a) and anti-GM1 (b) antibodies. Alexa-488 was used 
to visualize AQP5 and GM1. Propidium iodide (PI) was used to stain nuclei. One section is 
presented in each single image (−1). Sixteen consecutive images produced by a confocal microscope 
were projected to generate a single image (−2). To get clear visualization of AQP5 localization in 
acinar cells, the 568 nm laser was turned oﬀ (−3). Arrow heads and arrows indicate apical plasma 
membrane (APM) and lateral plasma membrane (LPM), respectively. Scale bars: 10 µm. 
2.2. Prevention of α1-AR Agonist-Induced Trafficking of AQP5 and GM1 by Phentolamine 
Previous in vitro experiments showed that phentolamine (nonspecific α1-AR antagonist) 
inhibited the epinephrine-induced increases of AQP5 in the APM [9]. To visualize the effect of an 
α1-AR antagonist on the subcellular distribution of AQP5 (Figure 2a) and GM1 (Figure 2b) in vivo, 
phentolamine or saline were injected intraperitoneally. Sixty minutes after saline-injection, AQP5 
(Figure 2a; A) and GM1 (Figure 2b; A) staining were observed throughout the cytoplasm, with little 
AQP5 in the APM and LPM. Sixty minutes after the phentolamine or saline injection, phenylephrine 
Figure 1. Immunohistochemical analysis of aquaporin-5 (AQP5) and ganglioside GM1 distributions
in rat parotid acinar cells after phenylephrine injection. Parotid glands were obtained from rats 0 (A),
3 (B), 6 (C), and 10 (D) min after phenylephrine (0.25 mg/kg) injection. Tissue sections were fixed
in ethanol followed by incubation with anti-AQP5 (a) and anti-GM1 (b) antibodies. Alexa-488 was
used to visualize AQP5 and GM1. Propidium iodide (PI) was used to stain nuclei. One section is
presented in each single image (´1). Sixteen consecutive images produced by a confocal microscope
were projected to generate a single image (´2). To get clear visualization of AQP5 localization in acinar
cells, the 568 nm laser was turned off (´3). Ar ow heads and arrows indicate apical plasma membrane
(APM) and lateral plasma membrane (LPM), respectively. Scale bars: 10 µm.
2.2. Prevention of α1-AR Agonist-Induced Trafficking of AQP5 and GM1 by Phentolamine
Previous in vitro experiments showed that phentolamine (nonspecific α1-AR antagonist) inhibited
the epinephrine-induced increases of AQP5 in the APM [9]. To visualize the effect of an α1-AR antagonist
on the subcellular distribution of AQP5 (Figure 2a) and GM1 (Figure 2b) in vivo, phentolamine or saline
were injected intraperitoneally. Sixty minutes after saline-injection, AQP5 (Figure 2a; A) and GM1
(Figure 2b; A) staining were observed throughout the cytoplasm, with little AQP5 in the APM and
LPM. Sixty minutes after the phentolamine or saline injection, phenylephrine (0.25 mg/kg) was
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injected into the tail vein (Figure 2a,b; B and D). Ten minutes later, AQP5 (Figure 2a; D) and GM1
(Figure 2b; D) were not accumulated in the APM and LPM of phentolamine-injected rat compared
with non-phentolamine-injected rats (Figure 2a,b; B). Saline was injected into the tail vein 60 min after
phentolamine-injection (Figure 2a,b; C). Ten minutes later, AQP5 (Figure 2a; C) and GM1 (Figure 2b; C)
showed similar staining patterns to those of control (Figure 2a,b; A). These results indicate that
phentolamine prevented the phenylephrine-induced increases in AQP5 and GM1 in the APM and LPM.
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(B and D) was intravenously injected. Parotid glands were obtained from rats 0 (A) and 10 (B–D) 
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Figure 2. Immunohistochemical analysis of AQP5 and GM1 distributions in rat parotid acinar cells after
phenylephrine and phentolamine injection. Rats were intraperitoneally injected with phentolamine
(10 mg/kg) (C and D) or saline (A and B). After 60 min, phenylephrine (0.25 mg/kg) (B and D)
was intravenously injected. Parotid glands were obtained from rats 0 (A) and 10 (B–D) min after
phenylephrine or saline injection. Alexa-488 was used to visualize AQP5 (a) and GM1 (b). PI was used
to stain nuclei. One section is presented in each single image (´1). Sixteen consecutive images produced
by a confocal microscope were projected to generate a single image (´2). To get clear visualization of
AQP5 localization in the acinar cells, the 568 nm laser was turned off (´3). Arrow heads and arrows
indicate APM and LPM, respectively. Scale bars: 10 µm.
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2.3. Purity of APM Isolated from Rat Parotid Gland
To evaluate the purity and cross-contamination of the APM and basolateral plasma membrane
(BLM), isolated fractions were examined for the presence of enzymatic activities of γ-glutamyl
transpeptidase (γ-GT) and K+-stimulated p-nitrophenyl phosphatase (K+-NPPase) markers of APM
and BLM, respectively. The γ-GT activities in APMs and BLMs were 24 and 4 mU/mg protein,
respectively (Table S1). The K+-NPPase activities were 20 and 109 mU/mg protein in APMs and BLMs,
respectively (Table S1). When the γ-GT activity in APM was more than five times higher than in
BLM, and the K+-NPPase activity was less than one-fifth of that in BLM, APM samples were used in
further experiments.
2.4. Effects of Antagonists of α1-AR Subtypes on the Phenylephrine-Induced Trafficking of AQP5
Some studies describe a high incidence of dry mouth as a side effect of treatment with
α1-AR antagonists [24]. Therefore, to identify the specific α1-AR subtype accountable for the
phenylephrine-induced trafficking of AQP5, rat parotid tissue slices were incubated with specific
α1-AR antagonists. Incubation of tissues for 10 min with 1 µM phenylephrine induced a 1.8-fold
increase in the amount of AQP5 in the APM (Figure 3a,c; lane 2). The effect of phenylephrine was
inhibited by the α1A-adrenergic specific antagonist silodosin (10 µM) (Figure 3a,c; lane 3). However,
neither the α1B-AR antagonist L765314 (10 µM) (Figure 3a,c; lane 4) nor the α1D-AR antagonist
BMY7378 (10 µM) (Figure 3a,c; lane 5) had significant effects on the amount of AQP5 in the APM.
These results suggest that phenylephrine acts at the α1A-AR to promote the trafficking of AQP5 to the
APM in rat parotid cells.
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In the western blotting, Ponceau S staining of nitrocellulose membrane was used to assess equal
loading of proteins (Figure 3b). The levels of protein were corrected for whole protein loading [34] and
Ponceau S staining is considered to be a valuable tool for normalization of western blots due to its
advantages over housekeeping proteins [35].
2.5. Prevention of Phenylephrine-Induced Trafficking of AQP5 by α1A-AR Antagonist
In light of the results obtained from the in vitro experiment, we next sought to determine if AQP5
trafficking in vivo was disrupted by the α1A-AR specific antagonist silodosin. In order to directly
visualize the effect of silodosin on phenylephrine-induced translocation of AQP5 to the APM and
LPM, phenylephrine (0.25 mg/kg) was injected after the oral administration of silodosin at a daily
dose of 1 mg/kg for 1 week. In the parotid glands of control rats, AQP5 labeling (Figure 4; A-1) was
present in the APM, scattered in LPM, throughout the cytoplasm and in the apical plasmalemmal
region. After 10 min of phenylephrine injection, AQP5 was mainly localized in the APM and LPM
(Figure 4; B-1). Silodosin plus saline (Figure 4; C-1) and silodosin plus phenylephrine (Figure 4; D-1)
treatment of rat parotid tissue resulted in inhibition of AQP5 trafficking to the APM and LPM. Confocal
laser microscopy demonstrated that the AQP5 staining was confined to the same compartments as
in control rats. E-cadherin is considered to be a marker of the LPM [36]. To confirm trafficking of
AQP5 to the LPM, an antibody against E-cadherin was used. E-cadherin immunolocalization was
similar among the saline (Figure 4; A-2), saline plus phenylephrine (Figure 4; B-2), silodosin plus
saline (Figure 4; C-2) and silodosin plus phenylephrine (Figure 4; D-2) treated rat parotid acinar cells.
The results confirm that phenylephrine-induced AQP5 is trafficking to the APM and LPM via α1A-AR.
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2.6. Effects of ODQ and KT5823 on AQP5 Levels in the APM of Phenylephrine-Stimulated Parotid Tissue
In a previous study, the nitric-oxide (NO)/cGMP signaling pathway has been shown to play
a pivotal role in Ca2+ homeostasis in the mAChR-stimulated rise in AQP5 levels in the APM of rat
parotid tissue [37]. To investigate whether the NO/cGMP/PKG pathway affects AQP5 levels in the
APM of phenylephrine-stimulated parotid gland, the tissue was incubated with ODQ or KT5823,
inhibitors of NO-stimulated guanylyl cyclase (GC) and PKG, respectively. Treatment of the tissue
for 10 min with 10 µM of KT5823 prevented the increase in AQP5 levels in the APM induced by
phenylephrine (Figure 5c,d; lane 3). Similar results were obtained after incubation of the gland with
10 µM ODQ, in which the inhibitor abrogated the phenylephrine-induced increase of AQP5 in the
APM (Figure 5a,b; lane 3). In both cases, treatment of the gland with the inhibitors alone did not have
a significant effect on the level of AQP5 in the APM (Figure 5a–d; lane 4). The present results support
the participation of the NO/cGMP/PKG signaling pathway in the α1-adrenoceptor-stimulated rise in
AQP5 trafficking to the APM of the rat parotid gland.
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2.7. Effect of Differential Osmolality on AQP5 Trafficking to the APM in Parotid Tissues 
Hypotonicity induced the trafficking of AQP5 to the APM in cultured cells from human 
submandibular and parotid glands [28], whereas it reduced AQP5 abundance in lung epithelial  
cells [29]. Hyperosmolar perfusion of the perilymphatic fluid induced a significant increase of AQP5 
in the APM, but decreased AQP5 in the cytoplasm, in cochlea [30]. To evaluate the physiological 
relevance of changes in tonicity-triggered AQP5 translocation, rat parotid tissue slices were 
Figure 5. Effects of the antagonists ODQ and KT5823 on phenylephrine-induced increases in AQP5
levels in the APM. (a) Tissue slices from rat parotid glands were incubated for 10 min at 37 ˝C in
the absence (lanes 1 and 4) or presence of 1 µM phenylephrine (lanes 2 and 3) plus 10 µM ODQ
(lanes 3 and 4). The 5 µg of APM fraction protein was loaded on SDS-PAGE and processed by
immunoblot analysis with anti-AQP5 a tibody. Densitometric analysis was carried out normalizing
to total protein amount by staining membrane with Ponceau S solution. The m m ran stained with
Ponceau S was shown in Figure S1; (b) The amount AQP5 in the APM, measured by the intensity
of chemiluminescence, was shown as a percentage of the value for control tissue; (c) Tissue slices
from rat parotid glands were incubated for 10 min at 37 ˝C in the absence (lanes 1 and 4) or presence
of 1 µM phenylephrine (lanes 2 and 3) plus and 10 µM KT5823 (lanes 3 and 4). The 5 µg of APM
fraction protein was loaded on SDS-PAGE and processed by immunoblot analysis with anti-AQP5
antibody; (d) Densitometric analysis was carried out normalizing to total protein amount by staining
membrane with Ponceau S solution. The amount of AQP5 in the APM, measured by the intensity of
chemiluminescence, was shown as a percentage of the value for control tissue. Values are expressed as
mean ˘ SE of three independent experiments. ** p < 0.01, *** p < 0.01 vs. the value for control tissue.
2.7. Effect of Differential Osmolality on AQP5 Trafficking to the APM in Parotid Tissues
Hypotonicity induced the trafficking of AQP5 to the APM in cultured cells from human
submandibular and parotid glands [28], whereas it reduced AQP5 abundance in lung epithelial
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cells [29]. Hyperosmolar perfusion of the perilymphatic fluid induced a significant increase of AQP5
in the APM, but decreased AQP5 in the cytoplasm, in cochlea [30]. To evaluate the physiological
relevance of changes in tonicity-triggered AQP5 translocation, rat parotid tissue slices were incubated
in isotonic (264 mOsm/kg), hypertonic (491 and 700 mOsm/kg) and hypotonic (132 and 87 mOsm/kg)
solutions, and at the designated time, APM fractions were prepared and submitted to immunoblot
analysis. Results revealed that AQP5 protein was induced maximally (1.6-fold) when the tissue
was incubated in 87 mOsm/kg solution (Figure 6a,b; lane 5) and to a lesser extent (1.25-fold) by
incubation in 132 mOsm/kg solution (Figure 6a,b; lane 4). Results also showed that AQP5 surface
localization did not change significantly after 10 min of hypertonic challenges, neither at 491 nor at
700 mOsm/kg (Figure 6a,b; lanes 2 and 3). These data suggest that hypoosmolarity and its threshold,
but not hyperosmolarity, induce AQP5 translocation to the APM in the rat parotid gland.
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I r i vivo experiments using the rat parotid gland, α1-adrenoce t r a ist-i c
traffic ing of AQP5 showed a time-dependent i crease in the APM, with a peak at 6–10 min. To examine
whether hypotonicit -induced increases of AQP5 in the PM are also time-dependent, parotid sectio s
were analyzed at 0, 3, 6, 10 and 30 min after incubation in hypotonic solution. For the contr l,
parotid tissue was incubated for 0 min in hypotonic soluti (Fig re 6c,d; lane 1). AQP5 protein
increased in the APM at 3 min (Figure 6c,d; lane 2) after exposure to hypotonic soluti and peaked at
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6–10 min, reaching 130% and 150% of the control (0 min) level, respectively (Figure 6c,d; lanes 3 and 4).
Prolonged incubation (30 min) in hypotonic solution resulted in a reduction of AQP5 to the baseline
level (Figure 6c,d; lane 5). These data are highly similar to the time-dependent increase of AQP5 levels
in the APM of rat parotid tissues induced by phenylephrine.
To visualize hypotonicity-induced trafficking of AQP5, parotid sections were incubated for 10 min
in isotonic (Figure 7; A), hypertonic (Figure 7; B) and hypotonic (Figure 7; C) solutions and then were
analyzed by confocal microscopy. In isotonic and hypertonic conditions, large amount of AQP5 were
diffusely distributed throughout the cytoplasm, and the apical plasmalemmal region and scattered
in LPM. In hypotonic condition, AQP5 was distributed predominantly in the APM and LPM. Thus,
hypotonicity induced the trafficking of AQP5 to the APM and LPM in rat parotid glands.
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translocation of AQP5 to the APM. Rat parotid gland slices were incubated with (Figure 8a,b;  
lanes 3, 3’ and 4) or without (Figure 8a,b; lanes 1, 2, 1’ and 2’) lanthanum chloride heptahydrate 
Figure 7. Immunohistochemical analysis of AQP5 distribution in rat parotid acinar cells under isotonic,
hypertonic and hypotonic conditions. Parotid gland tissue sections were incubated for 10 min at
37 ˝C in isotonic (A), hypertonic (B) and hypotonic (C) solutions. Tissue sections were fixed in ethanol
followed by incubation with anti-AQP5 antibody. Secondary antibody coupled to Alexa-488 was used
to visualize AQP5. PI was used to stain nuclei. One section is presented in each single image (´1).
Sixteen consecutive images produced by a confocal microscope were projected to generate a single
image (´2). To get clear visualization of the AQP5 localization in acinar cells, the 568 nm laser was
turned off (´3). Arrow heads and arrows indicate APM and LPM, respectively. Scale bars: 10 µm.
2.8. Effects of Calcium Channel Blockers on Phenylephrine- and Hypotonicity-Induced Translocation of AQP5
in Rat Parotid Tissue
Elevation of [Ca2+]i occurs by at least two routes in salivary glands. One is the release from
endoplasmic reticulum Ca2+ stores to the cytoplasm [2], while the other involves direct Ca2+ entry to
the cytoplasm from the extracellular space [28]. The store-operated Ca2+ entry mechanism (SOCE)
consists of calcium release-activated calciu cha el r tei ( rai) 1, transient receptor potential
channel (TRPC) 1, TRPC3, and stromal interacti l l ( I ) 1 as its critical components [2,38],
and is activa ed by Ca2+ store depletion from endoplasmic reticulum. Ca2+ entry into stores is needed
to sustain the elevation of [C 2+]i and saliv secret on. In th s experiment, we evaluated the effec of a
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SOCE and TRPV4 channel blocker on phenylephrine- and hypotonicity-induced translocation of AQP5
to the APM. Rat parotid gland slices were incubated with (Figure 8a,b; lanes 3, 3’ and 4) or without
(Figure 8a,b; lanes 1, 2, 1’ and 2’) lanthanum chloride heptahydrate (La3+) (store-operated Ca2+ entry
and TRPV antagonist) [39–41] in the presence (Figure 8a,b; lanes 2, 3) or absence (Figure 8a,b; lanes 1, 4)
of phenylephrine and in isotonic (Figure 8a,b; lane 1’) or hypotonic (Figure 8a,b; lane 2’) solution.
After 10 min of incubation, samples were subjected to further analysis. The results showed that 3 mM
La3+ significantly decreased the amount of AQP5 in the APM of rat parotid acinar cells stimulated by
phenylephrine (Figure 8a,b; lane 3) and hypotonicity (Figure 8a,b; lane 3’). These data suggest that
SOCE and TRPV4-mediated extracellular influx of Ca2+ plays an important role in phenylephrine- and
hypotonicity-induced trafficking of AQP5 in rat parotid glands, respectively.
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Figure 8. Effects of lanthanum chloride (La ) and ruthenium red (RR) on phenylephrine- or
hypotonicity-induced increases in AQP5 levels in the APM. (a) Tissue slices from rat parotid glands
were incubated for 10 min at 37 ˝C in isotonic (lanes 1-4 and 1’) or hypotonic (lanes 2’ and 3’) solution
without (lanes 1 and 4) or with 1 µM phenylephrine (lanes 2 and 3) plus 3 mM La3+ (lanes 3, 3’
and 4). The 5 µg of APM fraction protein was prepared and processed by immunoblot analysis with
anti-AQP5 antibody; (b) D ns ometric analysis was carried out normalizing to total prot in amount by
staining membrane with Ponceau S soluti and values were expressed as a percentage f the control.
The membrane stained with Ponceau S was shown in Figure S1; (c) Tissue slices from the glands were
incubated for 10 min at 37 ˝C in control (lane 1), phenylephrine (lane 2), phenylephrine with RR (lane 3),
hypotonic (lane 4) and hypotonic with phenylephrine solutions (lane 4). The osmolality of the solutions
were 261 mOsm/kg (lanes 1–3) and 87 mOsm/kg (lanes 4 and 5) with 1 µM of phenylephrine and
10 µM of RR as he final concentration. The 5 µg f APM fracti n protein was loaded on SDS-PAGE
and proc ssed by immunoblot analysis with anti-AQP5 antibody; (d) Densitometric analysis was
carried out normalizing to total protein amount by staining membrane with Ponceau S solution and
values were expressed as a percentage of the control. Values are expressed as mean ˘ SE of three to six
independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. control.
It has been shown that transient receptor potential (TRPV) 4 mediates the influx of extracellular
Ca2+ [42], and that AQP5 is necessary for the hypotonicity-induced activation of TRPV4 and for
regulation of cell volume recovery [28]. In the present work, we examined the effects of inhibition
pathways, connected with Ca2+, implicated in phenylephrine- and hypotonic-induced trafficking of
AQP5 to the APM. We therefore incubated rat parotid tissue sections in isotonic (Figure 8c,d; lane 1),
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isotonic with phenylephrine (Figure 8c,d; lane 2), isotonic with phenylephrine and ruthenium red
(RR) solutions (an inhibitor of multiple TRPV channels) [28,29] (Figure 8c,d; lane 3) as well as in
hypotonic (Figure 8c,d; lane 4) and hypotonic with RR solutions (Figure 8c,d; lane 5) for 10 min and
subjected the samples to western blotting. The obtained data showed that 10 µM RR, completely
blocked the translocation of AQP5 to APM in response to hypotonicity (Figure 8c,d; lane 5 vs. 4).
In contrast, the same concentration of RR did not significantly attenuate the phenylephrine-induced
increase of AQP5 in APM (Figure 8c,d; lane 3 vs. 2). This phenomenon may be a consequence of
inhibition of TRPV4 and a subsequent decrease in the intracellular Ca2+ concentration, which is known
to be critical in AQP5 trafficking and fluid secretion in salivary glands. The above results suggest
that although hypotonicity and phenylephrine are efficient stimulators of AQP5 trafficking, they may
induce trafficking of the protein to APM via distinct mechanisms.
2.9. Phenylephrine-Induced AQP5 Translocation to the APM in Rat Parotid Tissues under Hypotonicity
In order to investigate the combined effect of hypotonicity and phenylephrine-induced trafficking
to the APM, parotid tissue slices were incubated with (Figure 9a,b; lanes 2 and 4) or without (Figure 9a,b;
lanes 1 and 3) phenylephrine in isotonic solution (264 mOsm/kg) (Figure 9a,b; lanes 1 and 2) or
hypotonic solution (87 mOsm/kg) (Figure 9a,b; lanes 3 and 4) for 10 min. Under isotonic condition,
phenylephrine induced a 1.8-fold increase in AQP5 in the APM compared to the control (Figure 9,
lane 2 vs. 1), while the incubation of tissue in hypotonic solution containing phenylephrine induced
1.7-fold greater increase in AQP5 than hypotonicity alone (Figure 9, lane 4 vs. 3). These data indicate
that the extent of responsiveness of AQP5 trafficking to an α1-AR agonist under hypotonic condition
is the same as that under isotonic condition.
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osmolality of the solutions were 261 mOsm/kg (lanes 1, 2) and 87 mOsm/kg (lanes 3, 4) with 1 µM of 
phenylephrine as a final concentration. The 5 µg of APM fraction protein was loaded on SDS-PAGE 
and processed by immunoblot analysis with anti-AQP5 antibody; (b) Densitometric analysis was 
carried out normalizing to total protein amount by staining membrane with Ponceau S solution  
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was shown in Figure S1. Values are expressed as mean ± SE of three independent experiments.  
*** p < 0.001 vs. control.  
Figure 9. Phenylephrine-induced translocation of AQP5 in rat parotid tissues under hypotonicity.
(a) Tissue slices from rat parotid glands were incubated for 10 min at 37 ˝C in control (lane 1),
phenylephrine (lane 2), hypotonic (lane 3) and hypotonic with phenylephrine (lane 4) solutions.
The osmolality of the solutions were 261 mOsm/kg (lanes 1, 2) and 87 mOsm/kg (lanes 3, 4) with
1 µM of phenylephrine as a final concentration. The 5 µg of APM fraction protein was loaded on
SDS-PAGE and processed by immunoblot analysis with anti-AQP5 antibody; (b) Densitometric analysis
was carried out normalizing to total protein amount by staining membrane with Ponceau S solution
and values were expressed as a percentage of the control. The membrane stained with Ponceau
S was shown in Figure S1. Values are expressed as mean ˘ SE of three independent experiments.
*** p < 0.001 vs. control.
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3. Discussion
We previously showed that epinephrine acting at α1-ARs induces a rise in AQP5 levels in the
APM of rat parotid glands by increasing [Ca2+]i. This induced increase of AQP5 was abrogated by
phentolamine in vitro [9]. In the present study, we directly visualized the subcellular localization of
AQP5 and ganglioside GM1 in rat parotid acinar cells stimulated by phenylephrine. Under control
conditions, AQP5 and GM1 were distributed in large amounts throughout the cytoplasm and apical
plasmalemmal region of parotid acinar cells. However, phenylephrine administration activated
α1-adrenoceptor-induced trafficking of AQP5 and GM1 to the APM and LPM, peaking from 6 to 10 min
after injection. We investigated the effect of phentolamine on the subcellular distribution of AQP5 and
GM1 in rat parotid tissue. To restrain the tonic innervation of adrenergic nerve, phentolamine was
injected into abdominal cavity of rats. Sixty minutes after phentolamine-injection, phenylephrine or
saline was injected intravenously into the tail vein. Ten minutes after phenylephrine injection, AQP5
and GM1 remained in the same compartments as in the saline-injected rats. These results indicate that
phentolamine inhibited the phenylephrine-induced increase in AQP5 and GM1 in the APM and LPM
of rat parotid glands.
The luminal membrane represents only 7.5% of the total plasma membrane of the rat parotid
acinar cells, which constitute a very small area compared to BLM [43]. In the unstimulated conditions,
the portion of AQP5 localized in the APM sufficiently supports salivary secretion. However, upon
stimulation, when large volumes of water fluxes are required, the translocation of AQP5 to APM and
additionally to the LPM of parotid gland, effectively increase the appropriate membrane surface of the
cells thus, compensate its small apical area and transport comparably large volumes of fluid. Moreover,
the results of AQP5 knockout studies showed the decrease in both paracellular and transcellular water
transport in salivary glands, indicating that functions of these two pathways are linked [44]. In light
of these results, it can also be speculated that trafficking of AQP5 to LPM could be the mechanism
that supports water transport and saliva secretion through paracellular pathway in salivary glands
stimulated by activation of α1-AR.
Next, we investigated the α1-AR subtypes in relation to phenylephrine-induced trafficking of
AQP5. Silodosin, but not L765314 and BMY378, inhibited phenylephrine-induced trafficking of AQP5,
suggesting that α1-AR activation-induced trafficking of AQP5 is mediated by the α1A-AR. The α1A-AR
is distributed in the genitourinary system and plays a pivotal role in contraction of the vas deferens
and the neck of the bladder [45]. Antagonists of the α1A-AR are important in the treatment of LUTS
due to bladder obstruction in patients with decreased bladder blood flow [18], with benign prostatic
hyperplasia [19,20], or with urolithiasis [21] and urethra contraction [22]. The α1B-AR subtype is
localized in the spleen and nucleus accumbens, where it is involved in the regulation of spleen
contraction [45] and locomotion [46]. Chronic activation of the α1B-AR leads to a shorter lifespan
caused by cancer and neurodegeneration [47]. The α1D-AR subtype is present in blood vessels and
regulates arterial blood pressure via vasocontraction [48]. Antagonists of the α1D-AR are thought to be
therapeutically important in cardiovascular diseases occurring due to the α1D-AR [23]. Antagonists
of the α1-AR subtypes are important as treatments of many kinds of diseases. However, antagonists
have many kinds of effects [49]. Antagonists of the α1A-AR inhibit phenylephrine-induced salivary
secretion, resulting in xerostomia or dry mouth [24]. In the present study, we showed the inhibitory
mechanism in relation to loss of AQP5 trafficking.
The maximal amount of AQP5 protein in the APM of rat parotid glands stimulated by muscarinic
receptor and α1-AR agonists was 3- [11,37] and 1.8-fold higher than unstimulated condition,
respectively. Ten percent of patients who received silodosin orally (4 mg twice daily) felt thirsty,
whereas in placebo group only 4.5% of patients had the same symptom [19]. At therapeutic dose
(7.5 mg once daily) of darifenecin (muscarinic antagonist), 20% of patients with LUTS suffered from dry
mouth, while 4.5% of patients in placebo group experienced this adverse effect [50]. In the treatment
of LUTS, muscarinic antagonists contribute to the higher incidence of dry mouth compared with
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α1A-adrenergic antagonists, which may be correlated with proportionally higher stimulatory effect of
mAChR agonists on AQP5 trafficking in parotid gland.
The α1-AR couples to different signaling pathways [25,26]. The α1A-AR couples to
phosphatidylinositol turnover such as M1 and M3-mAChR signaling and the subsequent rise in
[Ca2+]i [45,51], while the α1B-AR activates MAPK/ERK1/2 [26]. In the Ca2+-mediated intracellular
signaling pathway mechanisms, an increase in [Ca2+]i plays an essential role in the stimulation of
Ca2+/calmodulin (CaM)-dependent proteins, e.g., myosin light chain kinase, CaM kinases, and NO
synthase [52,53]. It is generally recognized that NO activates GC, producing cGMP, which then
activates PKG [1,54]. In this study, to examine the possible role of cGMP/PKG signal transduction
on AQP5 levels in the APM of phenylephrine-stimulated parotid glands, the tissue was incubated
with ODQ or KT5823, inhibitors of NO-stimulated guanylyl cyclase and PKG, respectively. The results
revealed that phenylephrine-induced trafficking of AQP5 to the APM was attenuated by the use of
specific inhibitors, suggesting the involvement of cGMP and PKG in this mechanism.
Recently, aquaporin levels have been shown to be dynamically regulated by hypo- and
hypertonicity-induced [Ca2+]i increases in different cell types [28–31,55]. In the present study,
we investigated the responsiveness of AQP5 trafficking to phenylephrine under isotonic and hypotonic
conditions. Under isotonic conditions, La3+, but not RR, inhibited phenylephrine-induced trafficking
of AQP5, suggesting that SOCE may regulate α1-AR-induced trafficking of AQP5 to the APM in
parotid glands. RR and La3+ inhibited hypotonic-induced trafficking of AQP5 to the APM, suggesting
that TRPV activation and extracellular influx of Ca2+ may be required in this induction. Several studies
describe inhibitory effect of RR and La3+ on the hypotonicity-induced increase in [Ca2+]i via activation
of TRPV [41]. In parotid glands, hypotonicity induced trafficking of AQP5 to the APM and LPM
within minutes in consistency with data described previously [28]. In lung epithelial cells, hypotonicity
reduced the AQP5 abundance mediated by TRPV4 channel over a period of hours, supposing that
hypotonicity induced the trafficking of AQP5 to lysosomes [29]. The basis of this difference is not
clearly known, however the duration time of incubation in hypotonic condition might explain the
apparent discrepancy since long term exposure to osmotic stress has deleterious consequences on
protein degradation [56]. Moreover, NO donors [37] and NO induce trafficking of AQP5 to the APM
in rat parotid glands, but NO decreases cell surface expression of AQP5 in lung epithelial cells [57].
Differential signal transductions may affect trafficking of AQP5 in parotid glands and lung epithelial
cells. Furthermore, our studies showed that under hypotonic conditions, phenylephrine induced
a 2.4-fold higher trafficking of AQP5 to the APM than the control, suggesting that both SOCE and
TRPV may be involved in hypotonic condition. Taken together, SOCE and TRPV contributes to the
induction of AQP5 trafficking to APM probably via distinct mechanisms, however, connected by the
indispensable role of [Ca2+]i.
In the present study, we showed that phenylephrine-induced trafficking of AQP5 required
activation of PKG and enhancement of [Ca2+]i in parotid glands. In parotid glands, activation of
α1-ARs [51] and mAChRs [58], but not β-ARs [59,60], was reported to elevate [Ca2+]i levels. [Ca2+]i is
referred to as store-operated Ca2+ pool that is activated by the release of endoplasmic reticulum Ca2+,
which initiate SOCE [61]. Our previous studies showed that intravenous injection of A-23187 (Ca2+
ionophore which induces an increase in the [Ca2+]i), but not the incubation of the parotid tissues with
A-23187, induces trafficking of AQP5 to the APM [12], indicating that the enhancement of [Ca2+]i is
necessary but not sufficient for the translocation of AQP5 to APM. As described previously by us [4,10],
and others [62], lipid rafts were also required for AQP5 trafficking to the APM in parotid tissues. Upon
activation of α1A-AR, anchor proteins may mediate lipid raft-dependent trafficking of AQP5 to the
APM and LPM via the enhancement of [Ca2+]i in parotid glands. Although Rab 4 protein is reported
to be co-localized with AQP5 in parotid glands [63], Ca2+-dependent phospholipid-binding proteins
are also assumable to work as anchor protein for membrane-recruitment of AQP5.
Together our present data and previous studies [8,9,11,12,37] clearly indicate the involvement
of both mAChRs and α1-ARs in AQP5 trafficking to APM and LPM and its contribution to saliva
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secretion in rat parotid tissue. Indeed, parasympathetic nerves usually evoke most of the salivary
fluid secretion, while sympathetic nerves have less of a fluid evoking role. However, dual stimulation
is expecting to have better synergistic effect on secretion of large volume of fluid secretion across
the plasma membrane [1]. Therefore, the effects of impulses from sympathetic and parasympathetic
nerves on salivary secretion should be no longer dichotomized but rather considered as an integrated
signaling platform necessary for the proper function of salivary glands.
4. Materials and Methods
4.1. Materials
Phenylephrine hydrochloride and L765314 were obtained from Sigma Aldrich (Munich, Germany).
Phentolamine hydrochloride was purchased from Ciba-Geigy Japan (Tokyo, Japan). Silodosin
and Urief 4 mg capsule were obtained from Kissei Pharmaceutical Co., Ltd. (Azumino City,
Japan) and Daiichi Sankyo Company (Tokyo, Japan), respectively. 8-[2-[4-(2-Methoxyphenyl)-1
-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride (BMY7378) was purchased from
Funakoshi Co. (Tokyo, Japan). 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and KT5823
were from Calbiochem-Behring Co. (La Jolla, CA, USA). Ruthenium red and lanthanum chloride
heptahydrate were purchased from TCI (Tokyo, Japan) and Nacalai Tesque (Kyoto, Japan), respectively.
4.2. Animals
Eight-week-old male Wistar rats from SLC, Inc. (Shizuoka, Japan) were provided with standard
laboratory chow (MF; Oriental Yeast, Tokyo, Japan) and water ad libitum, and were maintained in a
temperature-controlled environment (22 ˘ 2 ˝C) with a 12-h dark/light cycle. All procedures were
performed in accordance with the guidelines established by the Animal Care Committee of Tokushima
University (Approval NO.:14120) (Tokushima, Japan).
4.3. Immunohistochemistry
Phenylephrine hydrochloride (0.25 mg/kg) [64] was intravenously injected into the rat tail vein.
At 0, 3, 6, 10 min after the injection, parotid glands were quickly removed, embedded in Jung tissue
freezing medium (Leica, Heidelberg, Germany), and rapidly frozen with liquid nitrogen. In another
group of animals, phenylephrine (0.25 mg/kg) was injected 60 min after intraperitoneal injection of
phentolamine hydrochloride (10 mg/kg) [65]. In the last group of rats, phenylephrine (0.25 mg/kg) was
injected after oral administration of silodosin at a daily dose of 1 mg/kg for 1 week [20]. Frozen sections
(7-µm thick) were cut, mounted on poly-L-lysine-coated glass slides, and immediately fixed for
30 min with prechilled (´20 ˝C) ethanol. After washing in phosphate buffered saline (PBS, pH 7.5),
sections were blocked by serum-free protein block (Dako, North America Inc., Carpinteria, CA,
USA) for 20 min, and stained as follows. Sections were incubated overnight at 4 ˝C with primary
antibodies: rabbit anti-AQP5 antibody (1:1000 dilution) generated in response to a synthetic peptide
(KGTYEPEEDWEDHREERKKTI) corresponding to the C-terminal amino acid sequence of AQP5 [8],
rabbit anti-ganglioside GM1 antibody (1:1000 dilution; Calbiochem-Novabiochem Co., Darmstadt,
Germany) and mouse anti-E-cadherin antibody (1:50 dilution; BD Bioscience, San Diego, CA, USA).
The labeling was visualized by incubation for 1 h with Alexa Fluor 488 donkey anti-rabbit and/or
Alexa Fluor 568 goat anti-mouse secondary antibody (1:1000 dilution; Alexa 488/568; Molecular
Probes Europe, Leiden, The Netherlands). To stain cell nuclei, sections were incubated with 0.5 µg/mL
RNase A and then with 2 µg/mL of PI for 1 h at 37 ˝C. Fluorescence images were captured using a
confocal laser scanning microscope (Leica TCS NT, Wetzlar, Germany).
4.4. Preparation of Rat Parotid Glands
Rats were anesthetized with chloroform and sacrificed by a blow to the head. The parotid
glands (300 mg wet weight) were quickly removed and placed in ice-cold Krebs-Ringer-Tris (KRT)
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buffer containing 120 mM NaCl, 4.8 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 1.0 mM CaCl2,
16 mM Tris-HCl, pH 7.4, and 5 mM glucose, which was aerated with O2 gas before the experiment.
The 0.4-mm thick slices were prepared from the parotid glands using a McIlwain Tissue Chopper
(Mickle Laboratory Engineering, Surrey, UK) followed by equilibrated with KRT buffer for 20 min at
37 ˝C with shaking, as described previously [11].
4.4.1. Incubation of Rat Parotid Gland Slices
The slices prepared from parotid tissue were further incubated for 10 min at 37 ˝C in KRT solution
with or without phenylephrine and/or phentolamine, silodosin, L765314, BMY7378, ODQ, KT5823,
RR, and La3+. Parotid tissues were also incubated in iso-, hypo-, and hypertonic solutions (10 min).
KRT solution was made hypertonic or hypotonic by the addition of higher tonicity solution and by
dilution with water, respectively. The following KRB solutions were used in the osmolality experiment:
isotonic (264 mOsm/kg, 120 mM NaCl), hypertonic KRT-NaCl (491 mOsm/kg, 240 mM NaCl and
700 mOsm/kg, 360 mM NaCl), hypotonic KRT-NaCl (132 mOsm/kg, 60 mM NaCl and 87 mOsm/kg,
40 mM NaCl). The tissue in the hypotonic solution was additionally incubated in the presence of
ruthenium red or phenylephrine.
4.4.2. Preparation of APM from Parotid Gland Slices
The APM fraction was prepared from rat parotid glands according to the modified method
of Longbottom and Van Heyningen [66]. In brief, after incubation, parotid gland slices were
homogenized using a glass homogenizer and a Teflon pestle in 20 volume of 5 mM HEPES buffer, pH
7.5, containing 50 mM mannitol and 0.25 mM MgCl2, followed by filtration of the homogenate
through 150 mesh-nylon bolting cloth. The filtrate was processed to differential centrifugation
steps, and the pellet collected after centrifugation at 35,000ˆ g for 30 min was suspended in the
buffer described above. After the addition of 1 M MgCl2 to give a final concentration of 10 mM,
the suspension was incubated for 30 min on ice with stirring followed by centrifugation at 3000ˆ g for
15 min. The resultant precipitate was marked as BLM and the supernatant was again centrifuged at
35,000ˆ g for 30 min for precipitation of APM. To assess the purity of APM, the isolated membrane
fractions were assayed for the activities of γ-glutamyltranspeptidase (γ-GT) as a marker of the
APM and K+-stimulated p-nitrophenyl-phosphatase as a marker of BLM according to methods of
Meister et al. [67] and Alves et al. [68], respectively. The activity was expressed as micromoles of
p-nitroaniline or p-nitrophenol released per minute (units) per mg of protein.
4.5. Immunoblot Analysis
The APM fraction was subjected to SDS-polyacrylamide gel electrophoresis (PAGE) on a 12.5%
gel. The separated proteins were transferred to a nitrocellulose membrane (Hybond ECL; Amersham
Biosciences, Little Chalfont, Buckinghamshire, UK) using a Trans-Blot apparatus (Bio-Rad, Hercules,
CA, USA). Blots were stained with Ponceau S (Nacalai Tesque, Kyoto, Japan) dye to confirm equal
protein content in all lanes. Membranes were soaked in PBS to remove the Ponceau S and blocked
with 0.1% Tween 20 in Tris-buffered saline, pH 7.4, overnight. Blots were then probed with antibody
against AQP5 (1:1500). Immune complexes were detected with horseradish peroxidase-conjugated
donkey anti-rabbit IgG, whole Ab (1:3000, GE Healthcare, Piscataway, NJ, USA) and ECL reagents
(Amersham Pharmacia Biotech, Little Chalfont, UK). Chemiluminescence was measured using a
Chemi Doc apparatus (Bio-Rad, Hercules, CA, USA), analyzed using Quantity One software (Bio-Rad,
Hercules, CA, USA), and normalized by Ponceau S staining [34,35].
4.6. Osmolality
The osmolality of all solutions employed was measured using a vapor pressure osmometer
(Vescor, model 5520; Logan, UT, USA).
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4.7. Statistical Analysis
Data are presented as mean ˘ standard error (SE), and were analyzed for statistical significance
using Student’s t-test or analysis of variance at all-time points. p Values < 0.05 were considered
statistically significant.
5. Conclusions
Rapid phenylephrine-induced AQP5 translocation to APM and LPM of rat parotid tissue occurred
via activation of α1A-AR subtype, but not α1B- and α1D-AR subtypes. The process was mediated by
the Ca2+/cGMP/PKG signaling pathway, which was associated with SOCE. Under non-stimulated
conditions, hypotonicity induced the trafficking of AQP5 to the APM. The extent of responsiveness
of AQP5 trafficking to an α1-AR agonist under hypotonic condition was the same as that under
isotonic condition.
Supplementary Materials: Supplementary materials can be found at http://www.mdpi.com/1422-0067/
17/7/1022/s1.
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Abbreviations
ACh Acetylcholine
APM Apical plasma membrane
AQP Aquaporin
AR Adrenergic receptor
BLM Basolateral plasma membrane
BMY7378 8-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-8-azaspiro[4.5]decane-7,9-dione dihydrochloride
CaM Calcium/calmodulin-dependent kinase
cGC Soluble guanylate cyclase
cGMP Cyclic guanosine monophosphate
γ-GT γ-glutamyl transpeptidase
GM Monosialotetrahexosylganglioside
HEK293 Human Embryonic Kidney 293 cells
HEPESr 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
K+-NPPase K+-stimulated p-nitrophenyl phosphatase
KRT buffer Krebs-Ringer-Tris buffer
KT5823 (9S,10R,12R)-2,3,9,10,11,12-Hexahydro-10-methoxy-2,9-dimethyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg: 31,21,11-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, methyl ester
L765314 [(2S)-4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-2-[[(1,1-dimethylethyl)amino]carbonyl]-1-piperazinecarboxylic acid]
LPM Lateral plasma membrane
LUTS Lower urinary tract symptoms
mAChR Muscarinic acetylcholine receptor
NOS Nitric-oxide synthase
ODQ 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
Orai Calcium release-activated calcium channel protein
PBS Phosphate buffered saline
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PE Phenylephrine
PK Protein kinase
RR Ruthenium red
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis
SOCE Store operated calcium entry
STIM Stromal Interaction Molecule
TRPC Transient receptor potential channel
TRPV Transient receptor potential vanilloid
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